Income Statement Neurizon Therapeutics Limited

Equities

NUZ

AU0000357261

Pharmaceuticals

Market Closed - Australian S.E. Other stock markets 11:15:30 11/07/2025 am IST			5-day change	1st Jan Change
0.1650 ^AUD	+3.12%		+3.12%	-2.94%

10/07	Neurizon Therapeutics Receives US FDA Support to Lift Clinical Hold on ALS Trial	MT
03/07	Elanco Animal Health Enters Into Licensing Agreement With Neurizon for Monepantel	MT

48f400b4976892.TbCxwktKPyy9CbOwv47VdSaTGoYvvaEsHWgjXJmlQJw.deHJryQcVhr-a-ry5tyvRmr7Q8BM5exEbVhGBMHRcek_-evzDRBbT8hvxA

Published financial data: NEURIZON THERAPEUTICS LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: June	2020	2021	2022	2023	2024
Revenues	31.96L	21.4L	33.81L	28.24L	-
Other Revenues, Total	9L	15.17L	11.29L	10L	8L
Total Revenues	41.2L	36.57L	45.1L	38.19L	8L
Cost of Goods Sold, Total	2L	2L	3L	13.36L	-
Gross Profit	38.74L	34.32L	41.96L	24.83L	8L
Selling General & Admin Expenses, Total	42.41L	38.52L	47.42L	43.01L	24.41L
Provision for Bad Debts	-	-	-	77.98T	-
Stock-Based Compensation (IS)	-	-	-	-	4L
R&D Expenses	6L	6L	8L	10.32L	38.47L
Depreciation & Amortization - (IS)	3L	3L	3L	3L	1.64T
Other Operating Expenses, Total	51.21L	47.05L	58.16L	57.37L	66.59L
Operating Income	-12.47L	-12.73L	-16.2L	-32.54L	-58.17L
Interest Expense, Total	-1L	-78.99T	-88.51T	-81.86T	-
Interest And Investment Income	3.29T	14.72T	536	81.02T	24.47T
Net Interest Expenses	-1L	-64.27T	-87.98T	-837	24.47T
EBT, Excl. Unusual Items	-13.62L	-13.37L	-17.08L	-32.55L	-57.92L
Asset Writedown	-	-	-	-29.57L	-31.07L
EBT, Incl. Unusual Items	-13.62L	-13.37L	-17.08L	-62.12L	-89L
Earnings From Continuing Operations	-13.62L	-13.37L	-17.08L	-62.12L	-89L
Earnings Of Discontinued Operations	-	-	-	-	12.27L
Net Income to Company	-13.62L	-13.37L	-17.08L	-62.12L	-76.73L
Net Income - (IS)	-13.62L	-13.37L	-17.08L	-62.12L	-76.73L
Net Income to Common Incl Extra Items	-13.62L	-13.37L	-17.08L	-62.12L	-76.73L
Net Income to Common Excl. Extra Items	-13.62L	-13.37L	-17.08L	-62.12L	-89L
Per Share Items
Net EPS - Basic	-0	-0	-0.01	-0.02	-0.02
Basic EPS - Continuing Operations	-0	-0	-0.01	-0.02	-0.02
Basic Weighted Average Shares Outstanding	30Cr	32Cr	32Cr	32Cr	37Cr
Net EPS - Diluted	-0	-0	-0.01	-0.02	-0.02
Diluted EPS - Continuing Operations	-0	-0	-0.01	-0.02	-0.02
Diluted Weighted Average Shares Outstanding	30Cr	32Cr	32Cr	32Cr	37Cr
Normalized Basic EPS	-0	-0	-0	-0.01	-0.01
Normalized Diluted EPS	-0	-0	-0	-0.01	-0.01
Supplemental Items
EBITDA	-10.94L	-11.09L	-14.53L	-30.81L	-58.15L
EBITA	-12.47L	-12.73L	-16.2L	-32.54L	-58.17L
EBIT	-12.47L	-12.73L	-16.2L	-32.54L	-58.17L
Total Revenues (As Reported)	41.23L	36.72L	45.11L	39L	-
Normalized Net Income	-9L	-8L	-10.68L	-20.34L	-36.2L
Interest on Long-Term Debt	-	-	-	-	-
Supplemental Operating Expense Items
General and Administrative Expenses	11.42L	14.64L	17.67L	16.61L	16.97L
Research And Development Expense From Footnotes	6L	6L	8L	10.32L	38.47L
Stock-Based Comp., SG&A Exp. (Total)	48.25T	2L	-46.34T	-10T	-
Stock-Based Comp., Other (Total)	-	-	-	-	4L
Total Stock-Based Compensation	48.25T	2L	-46.34T	-10T	4L

Fiscal Period: June	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	28.8L	30.2L	24.16L	27.06L	97.14L
Short Term Investments	4.29T	4.22T	4.22T	15.78T	10.16L
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	28.85L	30.24L	24.2L	27.22L	1.07Cr
Accounts Receivable, Total	3L	2L	2L	1L	18.49T
Other Receivables	12.97T	-	-	-	-
Total Receivables	3L	2L	2L	1L	18.49T
Inventory	9L	10.08L	10.43L	0	-
Prepaid Expenses	17.1T	62.54T	63.67T	85.69T	2L
Other Current Assets, Total	-	19.58T	18.99T	65.59T	1L
Total Current Assets	40.7L	43.57L	37.31L	30.21L	1.11Cr
Gross Property Plant And Equipment	48.71L	50.61L	51.15L	22.12L	-
Accumulated Depreciation	-13.02L	-16.06L	-18.77L	-22.11L	-
Net Property Plant And Equipment	35.69L	34.55L	32.38L	1.64T	-
Other Intangibles, Total	31.07L	31.42L	31.1L	31.07L	-
Other Long-Term Assets, Total	-	-	-	-	-
Total Assets	1.07Cr	1.1Cr	1.01Cr	61.3L	1.11Cr
Liabilities
Accounts Payable, Total	6L	6L	6L	9L	8L
Accrued Expenses, Total	1L	2L	2L	3L	34.08T
Short-term Borrowings	-	-	2L	-	-
Current Portion of Long-Term Debt	2L	38.21T	-	-	-
Current Portion of Leases	2L	1L	1L	2L	-
Other Current Liabilities	-	-	-	-	35T
Total Current Liabilities	10.58L	9L	11.66L	13.47L	9L
Long-Term Debt	38.21T	-	-	-	-
Long-Term Leases	10.79L	11.31L	10.37L	9L	-
Pension & Other Post Retirement Benefits	44.51T	30.38T	31.02T	3.34T	649
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	22.2L	20.73L	22.34L	22.41L	9L
Common Stock, Total	5.38Cr	5.53Cr	5.53Cr	5.76Cr	6.99Cr
Retained Earnings	-4.72Cr	-4.85Cr	-5.02Cr	-5.65Cr	-6.41Cr
Comprehensive Income and Other	19.56L	20.93L	27.48L	27.15L	44.25L
Total Common Equity	85.26L	88.8L	78.44L	38.89L	1.02Cr
Total Equity	85.26L	88.8L	78.44L	38.89L	1.02Cr
Total Liabilities And Equity	1.07Cr	1.1Cr	1.01Cr	61.3L	1.11Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	32Cr	32Cr	32Cr	35Cr	49Cr
ECS Total Common Shares Outstanding	30Cr	32Cr	32Cr	35Cr	45Cr
Book Value / Share	0.03	0.03	0.02	0.01	0.02
Tangible Book Value	54.19L	57.38L	47.35L	8L	1.02Cr
Tangible Book Value Per Share	0.02	0.02	0.01	0	0.02
Total Debt	14.72L	12.78L	13.85L	10.49L	0
Net Debt	-14.13L	-17.46L	-10.35L	-16.73L	-1.07Cr
Account Code - Inventory Valuation	5	5	5	5	-
Inventories - Raw Materials, Total	-	10.57T	10.57T	4.36T	-
Inventories - Work In Process, Total	-	52.88T	59.04T	-	-
Inventories - Finished Goods, Total	9L	9L	10L	10.51L	-
Machinery, Total	35.26L	36.35L	36.34L	16.54L	-
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	77.98T	-

Fiscal Period: June	2020	2021	2022	2023	2024
Net Income	-13.62L	-13.37L	-17.08L	-62.12L	-76.73L
Depreciation & Amortization - CF	3L	3L	3L	3L	1.64T
Depreciation & Amortization, Total	3L	3L	3L	3L	1.64T
(Gain) Loss From Sale Of Asset	-	-	-	180	-12.27L
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	-	-	32.52T	35.83L	31.07L
Stock-Based Compensation (CF)	48.25T	2L	-46.34T	-10T	4L
Provision and Write-off of Bad Debts	-	-	-	-	-
Other Operating Activities, Total	96.59T	45.89T	-	5L	-
Change In Accounts Receivable	-38.84T	55.73T	56.63T	-40.9T	1L
Change In Inventories	-2L	-2L	-34.92T	-4.22T	-
Change In Accounts Payable	-1L	2.01T	44.63T	3L	5L
Change in Other Net Operating Assets	73.13T	-7.06T	8.5T	-36.68T	-4L
Cash from Operations	-12.7L	-9L	-13.32L	-15.64L	-51.69L
Capital Expenditure	-30.23T	-1L	-43.38T	-34.76T	-
Divestitures	-	-	-	-	-2L
Sale (Purchase) of Intangible assets	-	-36.32T	-	-167	-
Investment in Marketable and Equity Securities, Total	-	-	-	-	-10L
Cash from Investing	-30.23T	-1L	-43.38T	-34.93T	-11.65L
Long-Term Debt Issued, Total	-	-	2L	-	-
Total Debt Issued	-	-	2L	-	-
Long-Term Debt Repaid, Total	-3L	-3L	-2L	-4L	-
Total Debt Repaid	-3L	-3L	-2L	-4L	-
Issuance of Common Stock	23.84L	15.82L	7L	24L	1.29Cr
Other Financing Activities, Total	-	-44.99T	-	-2L	4L
Cash from Financing	20.9L	12.16L	8L	18.89L	1.33Cr
Net Change in Cash	8L	1L	-6L	3L	70.08L
Supplemental Items
Cash Interest Paid	21.91T	33.1T	88.51T	81.86T	-
Levered Free Cash Flow	-9L	-6L	-8L	-4L	-36.53L
Unlevered Free Cash Flow	-8L	-6L	-7L	-4L	-36.53L
Change In Net Working Capital	3L	85.76T	-74.19T	-13.83L	4L
Net Debt Issued / Repaid	-3L	-3L	52.49T	-4L	-

Fiscal Period: June	2020	2021	2022	2023	2024
Profitability
Return on Assets	-8.06	-7.33	-9.63	-25.09	-42.14
Return on Total Capital	-8.77	-7.89	-10.45	-28.71	-47.94
Return On Equity %	-17.04	-15.37	-20.43	-105.88	-126.08
Return on Common Equity	-17.04	-15.37	-20.43	-105.88	-126.08
Margin Analysis
Gross Profit Margin %	94.03	93.84	93.03	65.02	100
SG&A Margin	102.93	105.34	105.15	112.61	290
EBITDA Margin %	-26.56	-30.33	-32.22	-80.68	-690.89
EBITA Margin %	-30.26	-34.81	-35.92	-85.19	-691.08
EBIT Margin %	-30.26	-34.81	-35.92	-85.19	-691.08
Income From Continuing Operations Margin %	-33.06	-36.57	-37.87	-162.64	-1.06T
Net Income Margin %	-33.06	-36.57	-37.87	-162.64	-911.61
Net Avail. For Common Margin %	-33.06	-36.57	-37.87	-162.64	-1.06T
Normalized Net Income Margin	-20.66	-22.86	-23.67	-53.26	-430.11
Levered Free Cash Flow Margin	-21.75	-16.83	-17.04	-11.01	-434.01
Unlevered Free Cash Flow Margin	-19.95	-15.48	-15.81	-9.67	-434.01
Asset Turnover
Asset Turnover	0.43	0.34	0.43	0.47	0.1
Fixed Assets Turnover	1.36	1.04	1.35	2.36	-
Receivables Turnover (Average Receivables)	11.49	7.93	15.83	16.93	-
Inventory Turnover (Average Inventory)	0.34	0.24	0.31	2.56	-
Short Term Liquidity
Current Ratio	3.85	4.78	3.2	2.24	12.42
Quick Ratio	3.02	3.58	2.23	2.13	12
Operating Cash Flow to Current Liabilities	-1.2	-1.03	-1.14	-1.16	-5.77
Days Sales Outstanding (Average Receivables)	31.87	46.01	23.06	21.56	-
Days Outstanding Inventory (Average Inventory)	1.09T	1.51T	1.19T	142.47	-
Average Days Payable Outstanding	457.59	541.94	607.51	-	-
Cash Conversion Cycle (Average Days)	666.66	1.02T	606.34	-	-
Long Term Solvency
Total Debt/Equity	17.26	14.39	17.66	26.97	-
Total Debt / Total Capital	14.72	12.58	15.01	21.24	-
LT Debt/Equity	13.1	12.74	13.22	22.9	-
Long-Term Debt / Total Capital	11.17	11.14	11.24	18.03	-
Total Liabilities / Total Assets	20.66	18.93	22.16	36.56	8.06
EBIT / Interest Expense	-10.52	-16.12	-18.31	-39.75	-
EBITDA / Interest Expense	-8.2	-12.34	-14.75	-35.76	-
(EBITDA - Capex) / Interest Expense	-8.46	-13.63	-15.24	-36.18	-
Total Debt / EBITDA	-1.51	-1.31	-1.06	-0.36	-
Net Debt / EBITDA	1.45	1.79	0.79	0.57	1.85
Total Debt / (EBITDA - Capex)	-1.47	-1.19	-1.03	-0.35	-
Net Debt / (EBITDA - Capex)	1.41	1.62	0.77	0.56	1.85
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-5.21	-11.24	23.33	-15.32	-3.66
Gross Profit, 1 Yr. Growth %	-3.47	-11.42	22.27	-40.82	-3.66
EBITDA, 1 Yr. Growth %	-18.86	1.35	31.02	112.04	340.04
EBITA, 1 Yr. Growth %	-18.04	2.11	27.27	100.82	252.95
EBIT, 1 Yr. Growth %	-18.04	2.11	27.27	100.82	252.95
Earnings From Cont. Operations, 1 Yr. Growth %	-12.2	-1.81	27.73	263.63	466.09
Net Income, 1 Yr. Growth %	-12.2	-1.81	27.73	263.63	23.53
Normalized Net Income, 1 Yr. Growth %	-12.2	-1.81	27.73	90.53	268.44
Diluted EPS Before Extra, 1 Yr. Growth %	-34.95	-7.93	27.27	259	389.92
Accounts Receivable, 1 Yr. Growth %	15.01	-18.72	-23.4	-20.01	-87.52
Inventory, 1 Yr. Growth %	40.17	17.55	3.46	-100	-
Net Property, Plant and Equip., 1 Yr. Growth %	44.57	-3.19	-6.28	-99.95	-
Total Assets, 1 Yr. Growth %	25.02	1.93	-7.99	-39.17	81.47
Tangible Book Value, 1 Yr. Growth %	24.62	5.9	-17.49	-83.49	1.21T
Common Equity, 1 Yr. Growth %	14.36	4.15	-11.67	-50.42	163
Cash From Operations, 1 Yr. Growth %	-18.28	-26.14	42.04	17.41	230.43
Capital Expenditures, 1 Yr. Growth %	-79.4	236.49	-57.35	-19.86	-
Levered Free Cash Flow, 1 Yr. Growth %	-21.62	-31.3	24.86	-45.28	-676.04
Unlevered Free Cash Flow, 1 Yr. Growth %	-26.16	-31.12	25.98	-48.21	-676.04
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	12.44	-8.28	4.63	2.2	-56.8
Gross Profit, 2 Yr. CAGR %	14.21	-7.53	4.07	-14.93	-55.21
EBITDA, 2 Yr. CAGR %	-32.64	-9.32	15.23	66.68	100.05
EBITA, 2 Yr. CAGR %	-29.8	-8.52	14	59.87	89.48
EBIT, 2 Yr. CAGR %	-29.8	-8.52	14	59.87	89.48
Earnings From Cont. Operations, 2 Yr. CAGR %	-26.51	-7.15	11.99	115.52	128.26
Net Income, 2 Yr. CAGR %	-26.51	-7.15	11.99	115.52	111.94
Normalized Net Income, 2 Yr. CAGR %	-26.51	-7.15	11.99	56	84.15
Diluted EPS Before Extra, 2 Yr. CAGR %	-48.29	-22.62	8.25	113.75	111.02
Accounts Receivable, 2 Yr. CAGR %	9.48	-3.32	-21.1	-21.73	-68.41
Inventory, 2 Yr. CAGR %	22.23	28.36	10.28	-	-
Net Property, Plant and Equip., 2 Yr. CAGR %	19.62	18.31	-4.75	-97.82	-
Total Assets, 2 Yr. CAGR %	13.39	12.89	-3.16	-25.19	5.06
Tangible Book Value, 2 Yr. CAGR %	15.95	14.88	-6.52	-63.09	46.98
Common Equity, 2 Yr. CAGR %	9.29	9.14	-4.08	-33.82	14.19
Cash From Operations, 2 Yr. CAGR %	-9.5	-22.31	2.42	29.14	96.97
Capital Expenditures, 2 Yr. CAGR %	-81.35	-16.74	19.79	-41.54	-
Levered Free Cash Flow, 2 Yr. CAGR %	-22.14	-26.62	-7.39	-17.34	118.02
Unlevered Free Cash Flow, 2 Yr. CAGR %	-24.98	-28.68	-6.85	-19.23	126.31
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	7.6	3.91	1.24	-2.5	-38.72
Gross Profit, 3 Yr. CAGR %	9.3	4.94	1.5	-13.78	-37.4
EBITDA, 3 Yr. CAGR %	-2.67	-22.81	2.52	41.21	73.72
EBITA, 3 Yr. CAGR %	-1.64	-20.46	2.12	37.68	65.94
EBIT, 3 Yr. CAGR %	-1.64	-20.46	2.12	37.68	65.94
Earnings From Cont. Operations, 3 Yr. CAGR %	0.45	-19.06	3.27	65.83	88.1
Net Income, 3 Yr. CAGR %	0.45	-19.06	3.27	65.83	79.03
Normalized Net Income, 3 Yr. CAGR %	0.45	-19.06	3.27	33.69	63.01
Diluted EPS Before Extra, 3 Yr. CAGR %	-24.73	-37.33	-8.66	61.43	78.29
Accounts Receivable, 3 Yr. CAGR %	10.24	-0.87	-10.54	-20.74	-57.56
Inventory, 3 Yr. CAGR %	20.78	20.65	19.46	-	-
Net Property, Plant and Equip., 3 Yr. CAGR %	26.96	11.47	9.47	-92.29	-
Total Assets, 3 Yr. CAGR %	9.45	9.43	5.45	-17.06	0.52
Tangible Book Value, 3 Yr. CAGR %	12.48	12.5	2.88	-47.56	21.25
Common Equity, 3 Yr. CAGR %	7.23	7.55	1.71	-23.02	4.82
Cash From Operations, 3 Yr. CAGR %	0.38	-15.43	-5	7.19	76.63
Capital Expenditures, 3 Yr. CAGR %	-19.07	-51.08	-33.38	4.77	-
Levered Free Cash Flow, 3 Yr. CAGR %	2.45	-25.32	-12.39	-22.29	81.05
Unlevered Free Cash Flow, 3 Yr. CAGR %	1.07	-27.08	-13.79	-23.4	86.17
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	11.68	6.11	6.4	3.22	-27.99
Gross Profit, 5 Yr. CAGR %	12.36	6.68	7.18	-3.51	-26.83
EBITDA, 5 Yr. CAGR %	-10.38	-8.65	4.13	5.02	33.94
EBITA, 5 Yr. CAGR %	-8.75	-7.23	4.34	5.16	30.77
EBIT, 5 Yr. CAGR %	-8.75	-7.23	4.34	5.16	30.77
Earnings From Cont. Operations, 5 Yr. CAGR %	-6.69	-19.38	4.92	19.76	41.82
Net Income, 5 Yr. CAGR %	-6.69	-19.38	4.92	19.76	37.68
Normalized Net Income, 5 Yr. CAGR %	-6.69	-6.34	4.92	5.24	30.15
Diluted EPS Before Extra, 5 Yr. CAGR %	-28.93	-36.94	-12.95	2.38	27.68
Accounts Receivable, 5 Yr. CAGR %	5.92	20.81	-3.56	-9.81	-41.01
Inventory, 5 Yr. CAGR %	-	25.65	16.46	-	-
Net Property, Plant and Equip., 5 Yr. CAGR %	42.33	13.68	13.18	-76.91	-
Total Assets, 5 Yr. CAGR %	2.45	11.85	4.22	-6.01	5.29
Tangible Book Value, 5 Yr. CAGR %	8.16	24.53	4.46	-27.97	18.66
Common Equity, 5 Yr. CAGR %	-0.72	12.07	2.55	-11.44	6.53
Cash From Operations, 5 Yr. CAGR %	-6.22	-10.13	1.19	0.17	27.17
Capital Expenditures, 5 Yr. CAGR %	-22.73	-41.62	-5.32	-47.47	-
Levered Free Cash Flow, 5 Yr. CAGR %	-5.33	-25.31	-1.6	-22.23	26.16
Unlevered Free Cash Flow, 5 Yr. CAGR %	-6.91	-26.41	-2.17	-24.04	26.83